Clinical Trial Update: Study to Evaluate Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and Oxcarbazepine [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetics and tolerability of multiple doses of eslicarbazepine acetate and oxcarbazepine in partial epilepsy; results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial Epilepsy

Drugs mentioned

• Oxcarbazepine (Oxcarbazepine)
• eslicarbazepine acetate (eslicarbazepine acetate)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Partial Epilepsy | Phase 1 | Status: COMPLETED | Results posted: 2014-12-19